CLINICAL_TRIALS
trial_result
· 2015-03-02
Clinical Trial Update: A Biomarker Study of Secukinumab in Rheumatoid Arthritis (RA) Patients [Phase 2]
Summary
Phase 2 biomarker study of secukinumab in rheumatoid arthritis has completed, with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2015-03-02